| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Institute of Signaling, Developmental Biology and Cancer Research, UMR Centre National de la Recherche Scientifique; 2 Unité Institut National de la Sante et de la Recherche Medicale, Equipe labellisée Ligue Nationale contre le Cancer; 3 Equipe Institut National de la Sante et de la Recherche Medicale and Laboratory of Clinical and Experimental Pathology, Faculté de Médecine, University of Nice-Sophia Antipolis; 4 Service Anatomo Pathologie Centre Antoine Lacassagne, Nice, France; and 5 Division of Signal Transduction and Growth Control, Deutsches Krebsforschungszentrum, Heidelberg, Germany
Requests for reprints: Gilles Pagès, Institute of Signaling, Developmental Biology and Cancer Research UMR Centre National de la Recherche Scientifique 6543, University of Nice-Sophia Antipolis, 33 Avenue de Valombrose, Nice, France 06189. Phone: 33-492-03-1237; Fax: 33-492-03-1235; E-mail: gpages{at}unice.fr.
Extracellular signal-regulated kinases (ERK) regulate cellular functions in response to a variety of external signals. However, the specific functions of individual ERK isoforms are largely unknown. Hence, we have investigated the specific function of ERK1 in skin homeostasis and tumorigenesis in ERK1 knockout mice. They spontaneously develop cutaneous lesions and hyperkeratosis with epidermis thickness. Skin hyperproliferation and inflammation induced by application of 12-O-tetradecanoylphorbol-13-acetate (TPA) is strongly reduced in mutant mice. ERK1/ mice are resistant to development of skin papillomas induced by 7,12-dimethylbenz(a)anthracene (DMBA) and promoted by TPA. Tumor appearance was delayed, their formation was less frequent, and their number and size were reduced. Keratinocytes obtained from knockout mice showed reduced growth and resistance to apoptotic signals, accompanied by an impaired expression of genes implicated in growth control and invasiveness. These results highlight the importance of ERK1 in skin homeostasis and in the process of skin tumor development. (Cancer Res 2006; 66(5): 2700-7)
This article has been cited by other articles:
![]() |
K. M. Ansari, J. E. Rundhaug, and S. M. Fischer Multiple Signaling Pathways Are Responsible for Prostaglandin E2-Induced Murine Keratinocyte Proliferation Mol. Cancer Res., June 1, 2008; 6(6): 1003 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bayo, A. Sanchis, A. Bravo, J. L. Cascallana, K. Buder, J. Tuckermann, G. Schutz, and P. Perez Glucocorticoid Receptor Is Required for Skin Barrier Competence Endocrinology, March 1, 2008; 149(3): 1377 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lefloch, J. Pouyssegur, and P. Lenormand Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels Mol. Cell. Biol., January 1, 2008; 28(1): 511 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Agostinis, M. Garmyn, and A. Van Laethem The Aryl Hydrocarbon Receptor: An Illuminating Effector of the UVB Response Sci. Signal., September 11, 2007; 2007(403): pe49 - pe49. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Chung, J. H. Park, M. J. Kim, H. O. Kim, J. K. Hwang, S. K. Lee, and K. K. Park Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-{kappa}B Carcinogenesis, June 1, 2007; 28(6): 1224 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fritsche, C. Schafer, C. Calles, T. Bernsmann, T. Bernshausen, M. Wurm, U. Hubenthal, J. E. Cline, H. Hajimiragha, P. Schroeder, et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation PNAS, May 22, 2007; 104(21): 8851 - 8856. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Wattenberg Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis Am J Physiol Cell Physiol, January 1, 2007; 292(1): C24 - C32. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otis and N. Gallo-Payet Differential Involvement of Cytoskeleton and Rho-Guanosine 5'-Triphosphatases in Growth-Promoting Effects of Angiotensin II in Rat Adrenal Glomerulosa Cells Endocrinology, November 1, 2006; 147(11): 5460 - 5469. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |